Anti-cancer effect of bio-reductive drug β-lapachon is enhanced by activating NQO1 with heat shock

International Journal of Hyperthermia

Volumn 24, Issue 2, 2008, Pages 161-169

  Song, Chang W ^a   Chae, Jongsun J ^b,c   Choi, Eun K ^b   Hwang, Tae S ^d   Kim, Chulhee ^e   Lim, Byung Uk Lim ^e   Park, Heon Joo ^e  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul Business School   (South Korea)

^d Konkuk University   (South Korea)

^e Inha University   (South Korea)

Author keywords

lapachone; Hyperthermia; NQO1

Indexed keywords

BETA LAPACHONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BATH; C3H MOUSE; CANCER CELL CULTURE; CANCER INHIBITION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CLONOGENESIS; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG SENSITIZATION; ENZYME ACTIVATION; FEASIBILITY STUDY; FEMALE; FIBROSARCOMA; HEAT SHOCK RESPONSE; HEATING; HINDLIMB; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MONOTHERAPY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; COMBINED MODALITY THERAPY; FIBROSARCOMA; HUMANS; HYPERTHERMIA, INDUCED; LUNG NEOPLASMS; MICE; NAD(P)H DEHYDROGENASE (QUINONE); NADPH DEHYDROGENASE; NAPHTHOQUINONES; NEOADJUVANT THERAPY; TEMPERATURE;

EID: 39549094661     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730701781895     Document Type: Article

References (43)

1. Blackburn, RV, Galofore, SS, Corry, PM and Lee, YJ (1998) Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. Cancer Res, 58, pp. 1358-1362.
2. Borrellli, MJ, Schoenherr, DM, Wong, A., Bernock, LJ and Corry, PM (2001) Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res, 61, pp. 1113-1121.
3. Huang, Q., Hu, JK, Lohr, F., Zhang, L., Brown, R., Lanzen, J., Little, JB, Dewhirst, MW and Li, CY (2000) Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res, 60, pp. 3435-3439.
4. Li, GC, He, F., Shao, X., Urano, M., Shen, L., Kim, D., Borrelli, M., Leiberl, SA, Gutin, PH and Ling, CC (2003) Adenovirum-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Cancer Res, 63, pp. 3268-3274.
5. Park, HJ, Ahn, KJ, Ahn, SD, Choi, E., Lee, SW, Williams, B., Kim, EJ, Griffin, R., Bey, EA and Bornmann, WG (2005) Susceptibility of cancer cells to β-lapachone is enhanced by ionizing radiation. Int J Radiation Oncol Biol Phys, 61, pp. 212-219.
6. Suzuki, M., Amano, M., Choi, J., Park, HJ, Williams, B., Ono, K. and Song, CW (2006) Synergistic effects of radiation and B-lapachone in DU-145 human prostate cancer cells in vitro. Radiation Res, 165, pp. 525-531.
7. Choi, EK, Terai, K., Ji, IM, Kook, YH, Park, KH, Oh, ET, Griffin, RJ, Lim, BU, Kim, JS and Lee, DS (2007) Upregulation of NAD(P)H: Quinone oxidoreductase (NQO1) by radiation potentiates the effect of bioreductive β-lapachone against cancer cells. Neoplasia, 9, pp. 634-642.
8. Park, HJ, Choi, EK, Choi, J., Ahn, K., Kim, EJ, Ji, IM, Kook, YH, Ahn, S., Williams, B. and Griffin, RJ (2005) Heat-induced up-regulation of NAD(P)H:qUinone oxidoreductase potentiates anticancer effects of β-lapachone. Clin Cancer Res, 11, pp. 8866-8871.
9. Gutierrez, PL (2000) The role of NAD(P)H oxidoreductase (DT-diaphorase) in the bioactivation of quinine-containing antitumor agents: A review. Free Radic Biol Med, 29, pp. 263-275.
10. Pan, SS, Forrest, GL, Akman, SA and Hu, LT (1995) NAD(P)H: Quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT116 cells. Cancer Res, 55, pp. 330-335.
11. Begleiter, A. and Fourie, J. (2004) Induction of NQO1 in cancer cells. Methods in Enzymol, 382, pp. 321-351.
12. Rauth, AM, Goldberg, Z. and Mirsa, V. (1997) DT-diaphorase: Possible roles in cancer chemotherapy and carcinogenesis. Oncol Res, 9, pp. 339-349.
13. Ross, D. and Siegel, D. (2004) NAD(P)H:qUinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods in Enzymol, 382, pp. 115-144.
14. Siegel, D., Beall, H., Senekowitach, C., Kasai, M., Arai, H., Gibson, NW and Ross, D. (1992) Bioreductive activation of mitomycin C by DT-diaphorease. Biol Chem, 31, pp. 7879-7885.
15. Loadman, PM, Bibby, MC and Phillips, RM (2002) Pharmacological approach towards used on the clinically inactive agent EO9. The development of indolequinone bioreductive drugs. Br J Pharmacol, 137, pp. 701-709.
16. Winski, SL, Swann, E., Hargreaves, RH, Dehn, DL, Butler, J., Moody, CJ and Ross, D. (2001) Relationship between NAD(P)H:qUinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol, 61, pp. 1509-1516.
17. Fitzsimmons, SA, Workman, P., Rever, M., Paull, K., Camalier, R. and Lewis, AD (1996) Reductase enzyme expression across the National Cancer Institute tumor cell line panel: Correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst, 88, pp. 259-269.
18. Begleiter, A. (2000) Clinical applications of quinone-containing alkylating agents. Front Bioscience, 5, p. E153.
19. Guo, W., Reigan, P., Siegel, D., Zirrolli, J., Gustafson, D. and Ross, D. (2005) Formation of 17-allyaminodemethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:qUinone oxidoreductase 1: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition. Cancer Res, 65, pp. 10006-10015.
20. Sharp, SY, Kelland, LR, Valenti, MR, Brunton, MA, Hobbs, S. and Workman, P. (2000) Establishment of an isogenic human colon tumor model for NQO1 gene expression: Application to investigate the role of DT-diaphorase in bioredcutive drug activation in vitro and in vivo. Mol Pharmacol, 58, pp. 1146-1155.
21. Marin, A., de Cerain, A Lopez, Hamilton, E., Lewis, AD, Martinez-Penuela, JM, Idoate, MA and Bello, J. (1997) DT-diaphorase and cytochrome B5 reductase in human lung and breast tumors. Br J Cancer, 76, pp. 923-929.
22. Siegel, D., Franklin, WA and Ross, D. (1998) Immunohistochemical detection of NAD(P)H:qUinone oxidoreductase in human lung and lung tumors. Clin Cancer Res, 4, pp. 2065-2070.
23. Blinsky, M. and Jaiswal, AK (1993) NAD(P)H: Quinone oxidoreductase 1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev, 12, pp. 103-117.
24. Cresteil, T. and Jaiswal, AK (1991) High levels of expression of the NAD(P)H: Quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol, 42, pp. 1021-1027.
25. Beall, HD, Murphy, AM, Siegel, D., Hargreaves, RH, Butler, J. and Ross, D. (1995) NAD(P)H: Quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: Quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Mol Pharmacol, 48, pp. 499-504.
26. Planchon, SM, Pink, JJ, Tagliarino, C., Varnes, ME and Boothman, DA (2001) β-lapachone-induced apoptosis in human prostate cancer cells: Involvement of Nqo/xip3. Exp Cell Res, 267, pp. 95-106.
27. Pink, JJ, Planchon, SM, Tagliarino, C., Varnes, ME, Siegel, D. and Boothman, DA (2000) NAD(P)H: Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J Biol Chem, 275, pp. 5416-5424.
28. Pink, JJ, Wuerzberger-Davis, S., Tagliarino, C., Planchon, SM, Yang, X., Froelich, CJ and Boothman, DA (2000) Activation of cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone mediated apoptosis. Exp Cell Res, 255, pp. 144-155.
29. Tagliarino, C., Pink, JJ, Dubyak, GR, Nieminen, AL and Boothman, DA (2001) Calcium is a key signaling molecule in beta-lapachone mediated cell death. J Biol Chem, 276, pp. 19150-19159.
30. Li, Y., Sun, X., LaMont, JT, Pardee, AB and Li, CJ (2003) Selective killing of cancer cells by β-lapachone: Direct checkpoint activation as a strategy against cancer. Proc Natl Acad Sci USA, 100, pp. 2674-2678.
31. Pardee, AB, Li, YZ and Li, C. (2002) Cancer therapy with β-lapachone. Current Cancer Drug Targets, 2, pp. 227-242.
32. Li, CJ, Li, YZ, Pinto, AV and Pardee, AB (1999) Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: Xombining drugs imposes different artificial checkpoints. Proc Natl Acad Sci USA, 96, pp. 13369-13374.
33. Li, CJ, Wang, C. and Pardee, AB (1995) Induction of apoptosis by beta-lapachon in human prostate cancer cells. Cancer Res, 55, pp. 3712-3715.
34. Huang, L. and Pardee, AB (1999) β-Lapachone induces cell cycle arrest and apoptosis in human colon cancer. Mol Med, 5, pp. 711-720.
35. Bentle, MS, Reinicke, KE, Dong, Y., Bey, EA and Bootheman, DA (2007) Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, B-lapachone. Cancer Res, 67, pp. 6936-6945.
36. Bey, EA, Bentle, MS, Reinicke, KE, Dong, Y., Yang, CR, Girard, L., Minna, JD, Bornmann, WG, Gao, J. and Boothman, DA (2007) An NQO1- and PARP1-1 mediated cell death pathway induced in non-small cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci USA, 1004, pp. 11832-11837.
37. Boothman, DA, Trask, DK and Pardee, AB (1989) Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase. Cancer Res, 49, pp. 605-612.
38. Jaiswal, AK (2000) Regulation of genes encoding NAD(P)H:qUinone oxidoreductases. Free Radic Biol Med, 29, pp. 254-262.
39. Dhakshinamoorthy, S., Jain, AK, Bloom, DA and Jaiswal, AK (2005) Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:qUinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem, 280, pp. 16891-16900.
40. Chen, S., Knox, R., Lewis, AD, Friedlos, F., Workman, P., Deng, PS, Fung, M., Ebenstein, D., We, K. and Tsai, TM (1995) Catalytic properties of NAD(P)H:qUinone acceptor oxidoreductase: Study involving mouse, rat, human, and mouse-rat chimeric enzyme. Mol Pharmacol, 47, pp. 934-939.
41. Chen, S., Knox, R., Wu, K., Deng, PS, Zhou, D., Bianchet, MA and Amzel, LM (1997) Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse. J Bio Chem, 272, pp. 1437-1439.
42. Danson, S., Ward, TH, Butler, J. and Ranson, M. (2004) DT-diaphorase: A target for new anticancer drugs. Cancer Treat Rev, 30, pp. 437-449.
43. Winski, SL, Swann, E., Hargreaves, RH, Dehn, DL, Butler, J., Moody, CJ and Ross, D. (2002) Relationship between NAD(P)H:qUinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol, 61, pp. 1509-1516.